INTERLEUKIN 15 STIMULATES PRODUCTION OF MATRIX METALLOPROTEINASE-9 AND TISSUE INHIBITOR OF METALLOPROTEINASE-1 BY HUMAN PERIPHERAL BLOOD MONONUCLEAR CELLS
- 28 February 2001
- Vol. 13 (4), 244-247
- https://doi.org/10.1006/cyto.2000.0818
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosisBrain, 1998
- IL-12 regulates VEGF and MMPs in a murine breast cancer modelInternational Journal of Cancer, 1998
- Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy.Journal of Clinical Investigation, 1998
- THE INTERLEUKIN-12/INTERLEUKIN-12-RECEPTOR SYSTEM: Role in Normal and Pathologic Immune ResponsesAnnual Review of Immunology, 1998
- Interleukin-12: A Cytokine at the Interface of Inflammation and ImmunityAdvances in Immunology, 1998
- IL-15 mRNA expression is up-regulated in blood and cerebrospinal fluid mononuclear cells in multiple sclerosis (MS)Clinical and Experimental Immunology, 1998
- The role of interleukin–15 in T–cell migration and activation in rheumatoid arthritisNature Medicine, 1996
- Inhibition of cartilage and bone destruction in adjuvant arthritis in the rat by a matrix metalloproteinase inhibitor.The Journal of Experimental Medicine, 1995
- Cooperative signaling by alpha 5 beta 1 and alpha 4 beta 1 integrins regulates metalloproteinase gene expression in fibroblasts adhering to fibronectin.The Journal of cell biology, 1995
- Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases.Journal of Clinical Investigation, 1994